Development Plan

2018

Preclinical Studies Completion

We expect to complete preclinical studies for LGM2605 in 2018

2019

Submit IND Application to FDA

LignaMed plans to submit an IND in 2019

2021

Clinical Studies Completed and NDA Filed with FDA

LignaMed plans to complete clinical studies in 2021 and file NDA

2022

FDA Approval & Product Launch